Vaccine Development Global Program

Developing new, affordable vaccines for the people who need them most

Vaccines are one of the most effective, affordable, and beneficial tools in public health. Because market forces alone are not always strong enough to drive the development of vaccines most urgently needed in lower-income countries, PATH’s Vaccine Development Global Program is stepping in to fill the gap. Find out more »

Online platform for immunization advocates launched

Advocacy for immunisationA new online advocacy platform, Advocacy for Immunisation, recently launched on to provide guidance and tools for developing immunization advocacy strategies in country. Developed by PATH and the International Vaccine Access Center/Johns Hopkins University and powered by Gavi, the Vaccine Alliance, the platform contains a step-by-step how-to for advocates working to strengthen immunization programs and increase vaccine coverage and equity. Visit the website »


blog: Dr. Kathy Neuzil says it’s time to rethink how we talk about routine immunization »

social media: PATH takes the reins of @Vaccines this week »

blog/video: Discussing the immunization gap with World Health Assembly experts »

blog: Protecting Kids series gives voice to vaccine stories from home and abroad»

article: New data on live attenuated flu vaccine safety in young children »


Sign up for our e-newsletter

Our e-newsletter, Vaccines for the Future, provides quarterly updates on our efforts to develop innovative, safe, effective, and affordable vaccines. It includes updates on our progress, partnerships, and specific activities. Sign up now »

Visit the Vaccine Resource Library

PATH’s Vaccine Resource Library (VRL) seeks to gather the world’s best immunization resources in a single, easy-to-use website. The VRL offers high-quality, scientifically accurate documents and links on specific diseases and topics in immunization. Learn more »

Banner photos, clockwise from left: PATH/Gabe Bienczycki; PATH/Chutima Suraratdecha; PATH.

Comments are closed.